252 related articles for article (PubMed ID: 36430344)
1. Systems Drug Design for Muscle Invasive Bladder Cancer and Advanced Bladder Cancer by Genome-Wide Microarray Data and Deep Learning Method with Drug Design Specifications.
Su PW; Chen BS
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430344
[TBL] [Abstract][Full Text] [Related]
2. Identifying Drug Targets of Oral Squamous Cell Carcinoma through a Systems Biology Method and Genome-Wide Microarray Data for Drug Discovery by Deep Learning and Drug Design Specifications.
Lin YC; Chen BS
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142321
[TBL] [Abstract][Full Text] [Related]
3. Drug Target Identification and Drug Repurposing in Psoriasis through Systems Biology Approach, DNN-Based DTI Model and Genome-Wide Microarray Data.
Zhan YP; Chen BS
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373186
[TBL] [Abstract][Full Text] [Related]
4. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.
Ting CT; Chen BS
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008
[TBL] [Abstract][Full Text] [Related]
5. Systems Drug Discovery for Diffuse Large B Cell Lymphoma Based on Pathogenic Molecular Mechanism via Big Data Mining and Deep Learning Method.
Yeh SJ; Yeh TY; Chen BS
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743172
[TBL] [Abstract][Full Text] [Related]
6. Systems Approach to Pathogenic Mechanism of Type 2 Diabetes and Drug Discovery Design Based on Deep Learning and Drug Design Specifications.
Chang S; Chen JY; Chuang YJ; Chen BS
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375269
[TBL] [Abstract][Full Text] [Related]
7. Genetic and Epigenetic Host-Virus Network to Investigate Pathogenesis and Identify Biomarkers for Drug Repurposing of Human Respiratory Syncytial Virus via Real-World Two-Side RNA-Seq Data: Systems Biology and Deep-Learning Approach.
Hsu BW; Chen BS
Biomedicines; 2023 May; 11(6):. PubMed ID: 37371627
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the Genome-Wide Genetic and Epigenetic Networks for Drug Discovery Based on Systems Biology Approaches in Colorectal Cancer.
Yeh SJ; Chen SW; Chen BS
Front Genet; 2020; 11():117. PubMed ID: 32211020
[TBL] [Abstract][Full Text] [Related]
9. Systems Medicine Design for Triple-Negative Breast Cancer and Non-Triple-Negative Breast Cancer Based on Systems Identification and Carcinogenic Mechanisms.
Yeh SJ; Hsu BJ; Chen BS
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802957
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study.
Zhang H; Shan G; Song J; Tian Y; An LY; Ban Y; Luo GH
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32391563
[TBL] [Abstract][Full Text] [Related]
11. Systems Medicine Design based on Systems Biology Approaches and Deep Neural Network for Gastric Cancer.
Yeh SJ; Chen BS
IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(5):3019-3031. PubMed ID: 34232888
[TBL] [Abstract][Full Text] [Related]
12. Investigating Core Signaling Pathways of Hepatitis B Virus Pathogenesis for Biomarkers Identification and Drug Discovery via Systems Biology and Deep Learning Method.
Chang S; Wang LH; Chen BS
Biomedicines; 2020 Aug; 8(9):. PubMed ID: 32878239
[TBL] [Abstract][Full Text] [Related]
13. Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides.
Woerl AC; Eckstein M; Geiger J; Wagner DC; Daher T; Stenzel P; Fernandez A; Hartmann A; Wand M; Roth W; Foersch S
Eur Urol; 2020 Aug; 78(2):256-264. PubMed ID: 32354610
[TBL] [Abstract][Full Text] [Related]
14. Multiple-Molecule Drug Design Based on Systems Biology Approaches and Deep Neural Network to Mitigate Human Skin Aging.
Yeh SJ; Lin JF; Chen BS
Molecules; 2021 May; 26(11):. PubMed ID: 34073305
[TBL] [Abstract][Full Text] [Related]
15. Gene network profiling in muscle-invasive bladder cancer: A systematic review and meta-analysis.
Isali I; McClellan P; Calaway A; Prunty M; Abbosh P; Mishra K; Ponsky L; Markt S; Psutka SP; Bukavina L
Urol Oncol; 2022 May; 40(5):197.e11-197.e23. PubMed ID: 35039218
[TBL] [Abstract][Full Text] [Related]
16. Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.
Pietzak EJ; Zabor EC; Bagrodia A; Armenia J; Hu W; Zehir A; Funt S; Audenet F; Barron D; Maamouri N; Li Q; Teo MY; Arcila ME; Berger MF; Schultz N; Dalbagni G; Herr HW; Bajorin DF; Rosenberg JE; Al-Ahmadie H; Bochner BH; Solit DB; Iyer G
Eur Urol; 2019 Feb; 75(2):231-239. PubMed ID: 30290956
[TBL] [Abstract][Full Text] [Related]
17. Investigating the Role of Obesity in Prostate Cancer and Identifying Biomarkers for Drug Discovery: Systems Biology and Deep Learning Approaches.
Yeh SJ; Chung YC; Chen BS
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164166
[TBL] [Abstract][Full Text] [Related]
18. Integrative analysis of the lncRNA-associated ceRNA network reveals lncRNAs as potential prognostic biomarkers in human muscle-invasive bladder cancer.
Lyu L; Xiang W; Zhu JY; Huang T; Yuan JD; Zhang CH
Cancer Manag Res; 2019; 11():6061-6077. PubMed ID: 31308745
[TBL] [Abstract][Full Text] [Related]
19. Network Biomarkers of Bladder Cancer Based on a Genome-Wide Genetic and Epigenetic Network Derived from Next-Generation Sequencing Data.
Li CW; Chen BS
Dis Markers; 2016; 2016():4149608. PubMed ID: 27034531
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity research in muscle-invasive bladder cancer based on differential protein expression analysis.
Liu PF; Cao YW; Jiang HP; Wang YH; Yang XC; Wang XS; Niu HT
Med Oncol; 2014 Sep; 31(9):21. PubMed ID: 25085780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
